Objective To assess whether routine preoperative preparation of the endomet
rium with danazol or GnRH analogues is really necessary for transcervical r
esection of the endometrium (TCRE).
Design A prospective open trial.
Setting Specialized arrangements in a private minimal access gynaecological
centre and a research institute, in Mumbai, India.
Participants 665 women who presented with excessive menstrual bleeding.
Interventions Random allocation into groups receiving either no preoperativ
e preparation, or danazol or gonadotrophin-releasing hormone (GnRH) analogu
es, or progesterones for preoperative preparation, followed by hysteroscopi
c resection of the endometrium.
Main outcome measures These included assessment of relief of symptoms, fail
ures and satisfaction rate. Total operating time, amount of fluid used and
absorbed, as well as complications observed over a period of 7 years were a
lso recorded.
Results The results of 665 TCRE procedures evaluated over a period of almos
t 7 years suggest that outcomes were not influenced by preoperative endomet
rial preparation. Lack of endometrial preparation was not associated with a
ny increase in the complication rate, in procedures carried out by an exper
ienced hysteroscopist. Routine endometrial preparation is not necessary, an
d it substantially increases the overall cost of the procedure, which is an
important consideration in developing countries. Preoperative endometrial
preparation is necessary; only occasionally, when large submucous (>3 cm) f
ibroids are to be resected, as it may reduce the operating time and complic
ation rate significantly Relief from excessive menstrual bleeding occurred
in 88% of patients, of whom 39% had amenorrhoea. Repeat TCRE was necessary
in only 3% of patients, and 3% finally underwent hysterectomy.
Conclusions TCRE can be conveniently performed by an experienced hysterosco
pist without routine endometrial preparation with danazol/GnRH analogues. O
ur study shows that the incidence of complications was low with successful
results in 88% of patients with excessive menstrual bleeding.